SEI Investments’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
SEI Investments's CCCC Position: Q3 2026 in Review
SEI Investments reduced its C4 Therapeutics (CCCC) stake by 28% in Q3 2026, selling an estimated $44.2K and leaving 30,520 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #3182.
SEI Investments first reported a position in CCCC in Q3 2022 and has held it in 9 quarters since. The position peaked at $198K in Q2 2026. 91 funds tracked by Wall St. Rank hold CCCC as of Q3 2026.
- SEI Investments held 30,520 shares of C4 Therapeutics worth $102K as of Q3 2026.
- SEI Investments sold 11,856 C4 Therapeutics shares in Q3 2026, an estimated $44.2K.
- C4 Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #3182 holding.
- SEI Investments first reported a position in C4 Therapeutics in Q3 2022 and has held it in 9 quarters since.
- SEI Investments's C4 Therapeutics position peaked at $198K in Q2 2026.
- 91 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.